| Divine Hospice Care 322 2nd Street Southwest, Willmar, MN, 56201 | |
| (320) 231-9757 |
News Archive
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
Individuals are less likely to regain lost weight when they get monthly tips straight from trained counselors rather than from a weight-loss Web site, according to results of a study by Johns Hopkins and other researchers.
Walgreens, the nation's largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia.
Mayo Clinic announced today that it has entered into an agreement with Oxford University Press (OUP) to jointly publish medical reference books and textbooks authored by Mayo Clinic physicians and researchers.
› Verified 3 days ago
| Name | Divine Hospice Care |
|---|---|
| Location | 322 2nd Street Southwest, Willmar, Minnesota |
| Hospice ID | 241597 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 330 |
News Archive
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
Individuals are less likely to regain lost weight when they get monthly tips straight from trained counselors rather than from a weight-loss Web site, according to results of a study by Johns Hopkins and other researchers.
Walgreens, the nation's largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia.
Mayo Clinic announced today that it has entered into an agreement with Oxford University Press (OUP) to jointly publish medical reference books and textbooks authored by Mayo Clinic physicians and researchers.
› Verified 3 days ago
| NPI Number | 1518391259 |
| Organization Name | Divine Home Care, Inc. |
| Address | 322 2nd St Sw Willmar, Minnesota, 56201 |
| Phone Number | (320)231-9757 |
News Archive
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
Individuals are less likely to regain lost weight when they get monthly tips straight from trained counselors rather than from a weight-loss Web site, according to results of a study by Johns Hopkins and other researchers.
Walgreens, the nation's largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia.
Mayo Clinic announced today that it has entered into an agreement with Oxford University Press (OUP) to jointly publish medical reference books and textbooks authored by Mayo Clinic physicians and researchers.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | Not Available | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | Not Available | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | Not Available | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | Not Available | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | Not Available | 97.3 |
| Patients who got timely treatment for shortness of breath | Not Available | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
Individuals are less likely to regain lost weight when they get monthly tips straight from trained counselors rather than from a weight-loss Web site, according to results of a study by Johns Hopkins and other researchers.
Walgreens, the nation's largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia.
Mayo Clinic announced today that it has entered into an agreement with Oxford University Press (OUP) to jointly publish medical reference books and textbooks authored by Mayo Clinic physicians and researchers.
› Verified 3 days ago
| Home Health Aides | 2 |
| Counselors | 0.5 |
| Homemakers | 0.25 |
| Medical Social Workers | 0.5 |
| Registered Nurses | 2 |
| Total Employees | 5.25 |
|---|
News Archive
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
Individuals are less likely to regain lost weight when they get monthly tips straight from trained counselors rather than from a weight-loss Web site, according to results of a study by Johns Hopkins and other researchers.
Walgreens, the nation's largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia.
Mayo Clinic announced today that it has entered into an agreement with Oxford University Press (OUP) to jointly publish medical reference books and textbooks authored by Mayo Clinic physicians and researchers.
› Verified 3 days ago
| Others | 0.5 |
| Total Volunteers | 0.5 |
|---|
News Archive
Biovest International, Inc., a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company's publicly-traded shares are now being quoted on the newly launched OTCQB™ Market. The upgraded stock listing is a direct result of Biovest filing its Annual Reports (on Form 10-K) and its Quarterly Reports (on Form 10-Q) with the Securities and Exchange Commission (SEC), as the Company advances plans to emerge from reorganization.
Inspirion Delivery Technologies, LLC, a specialty pharmaceutical company focused solely on the development of Abuse-Deterrent Formulations (ADFs) of opioid products, together with its financial partner Trygg Pharma Group, announced that the U.S. Food & Drug Administration has accepted for filing the New Drug Application ("NDA") submitted on November 21, 2014 for its investigational drug, MorphaBond ER, an extended-release (ER), abuse-deterrent formulation of morphine.
Individuals are less likely to regain lost weight when they get monthly tips straight from trained counselors rather than from a weight-loss Web site, according to results of a study by Johns Hopkins and other researchers.
Walgreens, the nation's largest drugstore chain and an industry leader with more than 17,000 certified or licensed immunizers, today announced it is offering H1N1 vaccine at more than 1,500 Walgreens pharmacies and select Take Care Clinics in 27 states, as well as the District of Columbia.
Mayo Clinic announced today that it has entered into an agreement with Oxford University Press (OUP) to jointly publish medical reference books and textbooks authored by Mayo Clinic physicians and researchers.
› Verified 3 days ago
| Rice Hospice Program Location: 301 Becker Avenue Southwest, Willmar, Minnesota, 56201 Phone: (320) 231-9757 |
| Divine Hospice Care Location: 322 2nd Street Southwest, Willmar, Minnesota, 56201 Phone: (320) 231-9757 |